6,790 reports of this reaction
2.4% of all AMLODIPINE BESYLATE reports
#5 most reported adverse reaction
DRUG INEFFECTIVE is the #5 most commonly reported adverse reaction for AMLODIPINE BESYLATE, manufactured by PFIZER LABORATORIES DIV PFIZER INC. There are 6,790 FDA adverse event reports linking AMLODIPINE BESYLATE to DRUG INEFFECTIVE. This represents approximately 2.4% of all 281,512 adverse event reports for this drug.
Patients taking AMLODIPINE BESYLATE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a less commonly reported adverse event for AMLODIPINE BESYLATE, but still significant enough to appear in the safety profile.
In addition to drug ineffective, the following adverse reactions have been reported for AMLODIPINE BESYLATE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 6,790 FDA reports for AMLODIPINE BESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 2.4% of all adverse event reports for AMLODIPINE BESYLATE, making it a notable side effect.
If you experience drug ineffective while taking AMLODIPINE BESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.